Changes to the Medicare Advantage Program Enhance Some Consumer Protections But Roll Back Others
CMS recently finalized policies as part of the 2027 Medicare Advantage final rule that both enhance consumer protections and roll...
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
Editorial Note On April 21, 2026, CMS announced that the BALANCE Model will not be implemented in Medicare Part D...
Key Facts about the Uninsured Population
How many people are uninsured? For the first time since 2019, the number of people without health coverage and the...
Health and Health Care for American Indian or Alaska Native People: Key Issues
Introduction Recent and forthcoming policy changes may have important implications for American Indian or Alaska Native (AIAN) people and could...
New Trump Administration Health-Related Visa Guidance Could Impact Millions of Noncitizens
Summary Media reports indicate that the Trump administration’s Department of State issued new guidance that directs visa officers to consider...
Tracking Key HHS Public Health Policy Actions Under the Trump Administration
January 20 Presidential Executive Orders precipitate removal of some HHS websites and health data. – In the first days of...
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford
About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy...
KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use
Key Takeaways With the Trump administration recently announcing several high-profile prescription drug pricing deals, the latest polling from KFF suggests...
